<img alt="" height="1" width="1" />Ironwood Pharmaceuticals Inc IRWD Financial and Strategic Analysis Review ...Jazzou (blog)The company's first-in-class compound, Linaclotide, is being evaluated in a Phase 3 program for the treatment of irritable bowel syndrome with constipation ...<nobr>and more »</nobr> |